Literature DB >> 9657609

Avian macrophage metabolism.

R R Dietert1, K A Golemboski.   

Abstract

This review considers the role of avian macrophages as a source of immune effector and immunoregulatory metabolites. Although considerable attention has been given to the importance of leukocytic cytokines, particularly the monokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and transforming growth factor-beta (TGF-beta), metabolites produced by macrophages appear to be of equal importance in determining the progression of immune responses. The three metabolite categories that have received the greatest attention are the reactive oxygen species (ROS), the reactive nitrogen intermediates (RNI), and the eicosanoids. Additionally, the xenobiotic metabolites produced via cytochrome P450 activity mediate some immune-environmental interactions. Each of these four metabolite categories is subject to different requirements for metabolite production, and each has distinct effector functions. An understanding of macrophage metabolite regulation could allow improvements in avian health management and production via the effective control of metabolite production. The present review considers prior and recent information on the production of the metabolites by avian macrophages. Additionally, the potential ramifications of metabolite production and regulation are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657609     DOI: 10.1093/ps/77.7.990

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  2 in total

1.  A printed superoxide dismutase coated electrode for the study of macrophage oxidative burst.

Authors:  Leslie A Hiatt; Jennifer R McKenzie; Leila F Deravi; Reese S Harry; David W Wright; David E Cliffel
Journal:  Biosens Bioelectron       Date:  2011-12-27       Impact factor: 10.618

2.  Experimental models of cryptococcosis.

Authors:  Wilber Sabiiti; Robin C May; E Rhiannon Pursall
Journal:  Int J Microbiol       Date:  2011-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.